SELLAS Life Sciences Group, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2014 | $43.4M | $80.5M | $23.7M |
| FY2015 | $68.6M | $82.1M | $1.4M |
| FY2016 | $11.4M | $6.4M | $6.0M |
| FY2017 | $31.5M | $33.5M | $2.3M |
| FY2018 | $11.7M | $16.9M | $5.3M |
| FY2019 | $10.5M | $16.6M | $7.3M |
| FY2020 | $18.1M | $46.0M | $35.3M |
| FY2021 | $5.9M | $26.3M | $21.4M |
| FY2022 | $16.1M | $20.9M | $17.1M |
| FY2023 | $14.2M | $6.2M | $2.5M |